KAREN MULHOLLAND: Open Payments
NPI 1275918294 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,834 in 90 payments from 14 companies in 2025. Trend: 2023 $1,893 · 2024 $1,539 · 2025 $1,834
Food & beverage: $1,834
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 33 | $605 |
| GlaxoSmithKline, LLC. | 20 | $345 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $175 |
| GENZYME CORPORATION | 5 | $132 |
| Amgen Inc. | 5 | $107 |
| Verona Pharma, Inc. | 4 | $99 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| Insmed, Inc. | 3 | $68 |
| ABBVIE INC. | 3 | $58 |
| Viatris Specialty LLC | 2 | $55 |
Products named: TEZSPIRE, NUCALA, DUPIXENT, FASENRA, OFEV, Ohtuvayre, AIRSUPRA, BREZTRI.
Industry payments across NY — which companies pay providers there.
